← Evidence map

ArticleNature reviews. Clinical oncology2013

Urological cancer: second-line option for metastatic RCC.

Vanessa MarchesiPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 23629471